Search
-
Isomorphic Labs in Talks at a $40–50B Valuation; No Drug Yet in Human Trials
…), led by 2024 Nobel laureate Demis Hassabis — is in early talks to raise new funding at a valuation of at lea…
…), led by 2024 Nobel laureate Demis Hassabis — is in early talks to raise new funding at a valuation of at lea…